StimAire
PrivateLast Round
Seed
Nov 18, 2019
Company Overview
StimAire is a medical device company that develops injectable neuromodulation technology for the treatment of obstructive sleep apnea and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
neuromodulationobstructive sleep apneaOSAinjectable medical devicehypoglossal nerve stimulationminimally invasive surgerysleep apnea treatmentimplantable neurostimulatorbioelectronic medicineCPAP alternativemedical devicewireless stimulationoffice-based procedurehealth IoTmedtech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StimAire Comparables
Compare StimAire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avivomed | 91% | |
| Vivamed, Inc. | 88% | |
| Cryosa | 87% |
StimAire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2019 |
StimAire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Desert Angels | Seed |
StimAire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
HeadquartersTucson, Arizona
Employee Range3
Year Founded2018
Last FundingNov 18, 2019
See something wrong or outdated?